152 related articles for article (PubMed ID: 6701182)
21. Trazodone and m-chlorophenylpiperazine. Concentration in brain and receptor activity in regions in the brain associated with anxiety.
Smith TM; Suckow RF
Neuropharmacology; 1985 Nov; 24(11):1067-71. PubMed ID: 4080105
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological profile of the novel antidepressant 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno-[2,3-d]pyrimidine monohydrate hydrochloride.
Eguchi J; Inomata Y; Yuasa T; Egawa M; Saito K
Arzneimittelforschung; 1997 Dec; 47(12):1337-47. PubMed ID: 9450161
[TBL] [Abstract][Full Text] [Related]
23. Effect of etoperidone on the depletion of brain 5-hydroxytryptamine and catecholamines induced respectively by p-chloromethamphetamine and 6-hydroxydopamine in rats.
Carruba MO; Parenti M; Ricciardi S; Picotti GB; Mantegazza P
Pharmacol Res Commun; 1979 Feb; 11(2):169-77. PubMed ID: 155821
[No Abstract] [Full Text] [Related]
24. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
25. In-vivo metabolism of 4-substituted arylpiperazines to pharmacologically active 1-arylpiperazines.
Caccia S
Boll Chim Farm; 1990 May; 129(5):183-9. PubMed ID: 1982054
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.
Oka M; Noda Y; Ochi Y; Furukawa K; Une T; Kurumiya S; Hino K; Karasawa T
J Pharmacol Exp Ther; 1993 Jan; 264(1):158-65. PubMed ID: 8093723
[TBL] [Abstract][Full Text] [Related]
27. Antinociceptive effects of trazodone and m-chlorophenylpiperazine (mCPP) in mice: interaction with morphine.
Valeri P; Pimpinella G; Morrone LA; Romanelli L
Gen Pharmacol; 1991; 22(1):127-31. PubMed ID: 2050281
[TBL] [Abstract][Full Text] [Related]
28. Role of the 5-HT2C receptor in improving weight-supported stepping in adult rats spinalized as neonates.
Kao T; Shumsky JS; Jacob-Vadakot S; Himes BT; Murray M; Moxon KA
Brain Res; 2006 Sep; 1112(1):159-68. PubMed ID: 16914121
[TBL] [Abstract][Full Text] [Related]
29. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
[TBL] [Abstract][Full Text] [Related]
30. N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-nitrophenyl) cyclohexanecarboxamide: a novel pre- and postsynaptic 5-hydroxytryptamine(1A) receptor antagonist active on the lower urinary tract.
Leonardi A; Guarneri L; Poggesi E; Angelico P; Velasco C; Cilia A; Testa R
J Pharmacol Exp Ther; 2001 Dec; 299(3):1027-37. PubMed ID: 11714892
[TBL] [Abstract][Full Text] [Related]
31. Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone.
Staack RF; Maurer HH
J Anal Toxicol; 2003; 27(8):560-8. PubMed ID: 14670134
[TBL] [Abstract][Full Text] [Related]
32. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
33. Acute cardiovascular toxicity of trazodone, etoperidone and imipramine in rats.
Lisciani R; Baldini A; Benedetti D; Campana A; Barcellona PS
Toxicology; 1978 Jun; 10(2):151-8. PubMed ID: 684760
[TBL] [Abstract][Full Text] [Related]
34. Behavioral effects of 1-(m-chlorophenyl)piperazine (m-CPP) in a rat model of tardive dyskinesia.
Samad N; Haleem MA; Haleem DJ
Pak J Pharm Sci; 2008 Jul; 21(3):262-8. PubMed ID: 18614422
[TBL] [Abstract][Full Text] [Related]
35. Anticholinergic, antihistaminic and cardiovascular effects of two new congeners of quipazine and trazodone.
Alhaider AA
Arzneimittelforschung; 1993 Nov; 43(11):1141-4. PubMed ID: 7904818
[TBL] [Abstract][Full Text] [Related]
36. Effect of trazodone on the firing rate of central monoaminergic neurons. Comparison with various antidepressants.
Scuvée-Moreau J; Dresse A
Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):299-301. PubMed ID: 7165436
[No Abstract] [Full Text] [Related]
37. [Methodical problems of psychopharmacology presented using the example of antidepressive agents].
Hoffmeister F
Arzneimittelforschung; 1969 May; 19(5):808-10. PubMed ID: 5819796
[No Abstract] [Full Text] [Related]
38. Psychopharmacological profile of dexamisole.
Przegaliński E; Bigajska K; Siwanowicz J
Pol J Pharmacol Pharm; 1980; 32(1):21-9. PubMed ID: 7454609
[TBL] [Abstract][Full Text] [Related]
39. Changed plasma prolactin levels after etoperidone and placebo.
Meco G; Casacchia M; Boni B; Cusimano G; Carta A; Iannuccelli M
Int J Clin Pharmacol Res; 1984; 4(2):117-20. PubMed ID: 6469437
[TBL] [Abstract][Full Text] [Related]
40. m-CPP induced hypolocomotion does not interfere in the assessment of memory functions in rats.
Khaliq S; Irfan B; Haider S; Haleem DJ
Pak J Pharm Sci; 2008 Apr; 21(2):139-43. PubMed ID: 18390444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
